Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

High-risk lesions diagnosed at MRI-guided vacuum-assisted breast biopsy: imaging characteristics, outcome of surgical excision or imaging follow-up.

Okamoto S, Chen ST, Covelli JD, DeMartini WB, Daniel BL, Ikeda DM.

Breast Cancer. 2019 Dec 14. doi: 10.1007/s12282-019-01032-8. [Epub ahead of print]

PMID:
31838725
2.

Influence of Menstrual Cycle Timing on Screening Breast MRI Background Parenchymal Enhancement and Diagnostic Performance in Premenopausal Women.

Dontchos BN, Rahbar H, Partridge SC, Lehman CD, DeMartini WB.

J Breast Imaging. 2019 Sep;1(3):205-211. doi: 10.1093/jbi/wbz022. Epub 2019 Jun 11.

PMID:
31538142
3.

Utility of Diffusion-weighted Imaging to Decrease Unnecessary Biopsies Prompted by Breast MRI: A Trial of the ECOG-ACRIN Cancer Research Group (A6702).

Rahbar H, Zhang Z, Chenevert TL, Romanoff J, Kitsch AE, Hanna LG, Harvey SM, Moy L, DeMartini WB, Dogan B, Yang WT, Wang LC, Joe BN, Oh KY, Neal CH, McDonald ES, Schnall MD, Lehman CD, Comstock CE, Partridge SC.

Clin Cancer Res. 2019 Mar 15;25(6):1756-1765. doi: 10.1158/1078-0432.CCR-18-2967. Epub 2019 Jan 15.

4.

ACR BI-RADS Assessment Category 4 Subdivisions in Diagnostic Mammography: Utilization and Outcomes in the National Mammography Database.

Elezaby M, Li G, Bhargavan-Chatfield M, Burnside ES, DeMartini WB.

Radiology. 2018 May;287(2):416-422. doi: 10.1148/radiol.2017170770. Epub 2018 Jan 9.

5.

Relationship between preoperative breast MRI and surgical treatment of non-metastatic breast cancer.

Onega T, Weiss JE, Goodrich ME, Zhu W, DeMartini WB, Kerlikowske K, Ozanne E, Tosteson ANA, Henderson LM, Buist DSM, Wernli KJ, Herschorn SD, Hotaling E, O'Donoghue C, Hubbard R.

J Surg Oncol. 2017 Dec;116(8):1008-1015. doi: 10.1002/jso.24796. Epub 2017 Nov 11.

6.

Utility of BI-RADS Assessment Category 4 Subdivisions for Screening Breast MRI.

Strigel RM, Burnside ES, Elezaby M, Fowler AM, Kelcz F, Salkowski LR, DeMartini WB.

AJR Am J Roentgenol. 2017 Jun;208(6):1392-1399. doi: 10.2214/AJR.16.16730.

7.

Screening Breast MRI Outcomes in Routine Clinical Practice: Comparison to BI-RADS Benchmarks.

Strigel RM, Rollenhagen J, Burnside ES, Elezaby M, Fowler AM, Kelcz F, Salkowski L, DeMartini WB.

Acad Radiol. 2017 Apr;24(4):411-417. doi: 10.1016/j.acra.2016.10.014. Epub 2016 Dec 13.

8.

Novel High Spatiotemporal Resolution Versus Standard-of-Care Dynamic Contrast-Enhanced Breast MRI: Comparison of Image Quality.

Morrison CK, Henze Bancroft LC, DeMartini WB, Holmes JH, Wang K, Bosca RJ, Korosec FR, Strigel RM.

Invest Radiol. 2017 Apr;52(4):198-205. doi: 10.1097/RLI.0000000000000329.

9.

Breast MRI in the Diagnostic and Preoperative Workup Among Medicare Beneficiaries With Breast Cancer.

Onega T, Weiss JE, Buist DS, Tosteson AN, Henderson LM, Kerlikowske K, Goodrich ME, O'Donoghue C, Wernli KJ, DeMartini WB, Virnig BA, Bennette CS, Hubbard RA.

Med Care. 2016 Jul;54(7):719-24. doi: 10.1097/MLR.0000000000000542.

10.

Costs of diagnostic and preoperative workup with and without breast MRI in older women with a breast cancer diagnosis.

Onega T, Tosteson AN, Weiss J, Alford-Teaster J, Hubbard RA, Henderson LM, Kerlikowske K, Goodrich ME, O'Donoghue C, Wernli KJ, DeMartini WB, Virnig BA.

BMC Health Serv Res. 2016 Feb 27;16:76. doi: 10.1186/s12913-016-1317-6.

11.

Screening MRI in Women With a Personal History of Breast Cancer.

Lehman CD, Lee JM, DeMartini WB, Hippe DS, Rendi MH, Kalish G, Porter P, Gralow J, Partridge SC.

J Natl Cancer Inst. 2016 Jan 7;108(3). pii: djv349. doi: 10.1093/jnci/djv349. Print 2016 Mar.

PMID:
26744477
12.

Concordance of BI-RADS Assessments and Management Recommendations for Breast MRI in Community Practice.

Lee AY, Ichikawa L, Lee JM, Lee CI, DeMartini WB, Joe BN, Wernli KJ, Sprague BL, Herschorn SD, Lehman CD.

AJR Am J Roentgenol. 2016 Jan;206(1):211-6. doi: 10.2214/AJR.15.14356.

13.

Factors Associated with Preoperative Magnetic Resonance Imaging Use among Medicare Beneficiaries with Nonmetastatic Breast Cancer.

Henderson LM, Weiss J, Hubbard RA, O'Donoghue C, DeMartini WB, Buist DS, Kerlikowske K, Goodrich M, Virnig B, Tosteson AN, Lehman CD, Onega T.

Breast J. 2016 Jan-Feb;22(1):24-34. doi: 10.1111/tbj.12522. Epub 2015 Oct 28.

14.

Availability of Advanced Breast Imaging at Screening Facilities Serving Vulnerable Populations.

Lee CI, Bogart A, Germino JC, Goldman LE, Hubbard RA, Haas JS, Hill DA, Tosteson AN, Alford-Teaster JA, DeMartini WB, Lehman CD, Onega TL.

J Med Screen. 2016 Mar;23(1):24-30. doi: 10.1177/0969141315591616. Epub 2015 Jun 15.

15.

Advanced Breast Imaging Availability by Screening Facility Characteristics.

Lee CI, Bogart A, Hubbard RA, Obadina ET, Hill DA, Haas JS, Tosteson AN, Alford-Teaster JA, Sprague BL, DeMartini WB, Lehman CD, Onega TL.

Acad Radiol. 2015 Jul;22(7):846-52. doi: 10.1016/j.acra.2015.02.011. Epub 2015 Apr 4.

16.

Screening magnetic resonance imaging recommendations and outcomes in patients at high risk for breast cancer.

Ehsani S, Strigel RM, Pettke E, Wilke L, Tevaarwerk AJ, DeMartini WB, Wisinski KB.

Breast J. 2015 May-Jun;21(3):246-53. doi: 10.1111/tbj.12396. Epub 2015 Mar 17.

17.

Accuracy of 3 T versus 1.5 T breast MRI for pre-operative assessment of extent of disease in newly diagnosed DCIS.

Rahbar H, DeMartini WB, Lee AY, Partridge SC, Peacock S, Lehman CD.

Eur J Radiol. 2015 Apr;84(4):611-6. doi: 10.1016/j.ejrad.2014.12.029. Epub 2015 Jan 8.

18.

Suspicious axillary lymph nodes identified on clinical breast MRI in patients newly diagnosed with breast cancer: can quantitative features improve discrimination of malignant from benign?

Rahbar H, Conlin JL, Parsian S, DeMartini WB, Peacock S, Lehman CD, Partridge SC.

Acad Radiol. 2015 Apr;22(4):430-8. doi: 10.1016/j.acra.2014.10.010. Epub 2014 Dec 6.

19.

Breast MRI BI-RADS assessments and abnormal interpretation rates by clinical indication in US community practices.

Lee CI, Ichikawa L, Rochelle MC, Kerlikowske K, Miglioretti DL, Sprague BL, DeMartini WB, Wernli KJ, Joe BN, Yankaskas BC, Lehman CD.

Acad Radiol. 2014 Nov;21(11):1370-6. doi: 10.1016/j.acra.2014.06.003. Epub 2014 Aug 7.

20.

Breast DCE-MRI: influence of postcontrast timing on automated lesion kinetics assessments and discrimination of benign and malignant lesions.

Partridge SC, Stone KM, Strigel RM, DeMartini WB, Peacock S, Lehman CD.

Acad Radiol. 2014 Sep;21(9):1195-203. doi: 10.1016/j.acra.2014.04.013. Epub 2014 Jul 4.

21.

Contralateral prophylactic mastectomy in the American College of Radiology Imaging Network 6667 trial: effect of breast MR imaging assessments and patient characteristics.

Rahbar H, Hanna LG, Gatsonis C, Mahoney MC, Schnall MD, DeMartini WB, Lehman CD.

Radiology. 2014 Oct;273(1):53-60. doi: 10.1148/radiol.14132029. Epub 2014 Jun 16.

22.

Geographic access to breast imaging for US women.

Onega T, Hubbard R, Hill D, Lee CI, Haas JS, Carlos HA, Alford-Teaster J, Bogart A, DeMartini WB, Kerlikowske K, Virnig BA, Buist DS, Henderson L, Tosteson AN.

J Am Coll Radiol. 2014 Sep;11(9):874-82. doi: 10.1016/j.jacr.2014.03.022. Epub 2014 Jun 2.

23.

Diffusion-weighted MRI: association between patient characteristics and apparent diffusion coefficients of normal breast fibroglandular tissue at 3 T.

McDonald ES, Schopp JG, Peacock S, DeMartini WB, Rahbar H, Lehman CD, Partridge SC.

AJR Am J Roentgenol. 2014 May;202(5):W496-502. doi: 10.2214/AJR.13.11159. Erratum in: AJR Am J Roentgenol. 2014 Sep;203(3):694. DeMartini, Wendy D [corrected to DeMartini, Wendy B].

24.

Patterns of breast magnetic resonance imaging use in community practice.

Wernli KJ, DeMartini WB, Ichikawa L, Lehman CD, Onega T, Kerlikowske K, Henderson LM, Geller BM, Hofmann M, Yankaskas BC; Breast Cancer Surveillance Consortium.

JAMA Intern Med. 2014 Jan;174(1):125-32. doi: 10.1001/jamainternmed.2013.11963.

25.

Breast magnetic resonance imaging technique at 1.5 T and 3 T: requirements for quality imaging and American College of Radiology accreditation.

DeMartini WB, Rahbar H.

Magn Reson Imaging Clin N Am. 2013 Aug;21(3):475-82. doi: 10.1016/j.mric.2013.04.004.

PMID:
23928238
26.

Radiologists' performance in the ACR Breast MR With Guided Biopsy course.

Lee CI, Grauke LJ, Sandhir V, Demartini WB, Newstead GM, Peacock S, Lehman CD.

J Am Coll Radiol. 2013 Nov;10(11):854-8. doi: 10.1016/j.jacr.2013.03.012. Epub 2013 May 25.

PMID:
23714721
27.

Accuracy and interpretation time of computer-aided detection among novice and experienced breast MRI readers.

Lehman CD, Blume JD, DeMartini WB, Hylton NM, Herman B, Schnall MD.

AJR Am J Roentgenol. 2013 Jun;200(6):W683-9. doi: 10.2214/AJR.11.8394.

28.

Clinical and technical considerations for high quality breast MRI at 3 Tesla.

Rahbar H, Partridge SC, DeMartini WB, Thursten B, Lehman CD.

J Magn Reson Imaging. 2013 Apr;37(4):778-90. doi: 10.1002/jmri.23834. Review.

29.

Accuracy and value of breast ultrasound for primary imaging evaluation of symptomatic women 30-39 years of age.

Lehman CD, Lee CI, Loving VA, Portillo MS, Peacock S, DeMartini WB.

AJR Am J Roentgenol. 2012 Nov;199(5):1169-77. doi: 10.2214/AJR.12.8842.

PMID:
23096195
30.

Nonmalignant breast lesions: ADCs of benign and high-risk subtypes assessed as false-positive at dynamic enhanced MR imaging.

Parsian S, Rahbar H, Allison KH, Demartini WB, Olson ML, Lehman CD, Partridge SC.

Radiology. 2012 Dec;265(3):696-706. doi: 10.1148/radiol.12112672. Epub 2012 Oct 2.

31.

Evaluation of tissue sampling methods used for MRI-detected contralateral breast lesions in the American College of Radiology Imaging Network 6667 trial.

DeMartini WB, Hanna L, Gatsonis C, Mahoney MC, Lehman CD.

AJR Am J Roentgenol. 2012 Sep;199(3):W386-91. doi: 10.2214/AJR.11.7000.

32.

Dynamic breast MRI: does lower temporal resolution negatively affect clinical kinetic analysis?

Gutierrez RL, Strigel RM, Partridge SC, DeMartini WB, Eby PR, Stone KM, Peacock S, Lehman CD.

AJR Am J Roentgenol. 2012 Sep;199(3):703-8. doi: 10.2214/AJR.11.7836.

PMID:
22915415
33.

Positive predictive value of BI-RADS MR imaging.

Mahoney MC, Gatsonis C, Hanna L, DeMartini WB, Lehman C.

Radiology. 2012 Jul;264(1):51-8. doi: 10.1148/radiol.12110619. Epub 2012 May 15.

34.

In vivo assessment of ductal carcinoma in situ grade: a model incorporating dynamic contrast-enhanced and diffusion-weighted breast MR imaging parameters.

Rahbar H, Partridge SC, Demartini WB, Gutierrez RL, Allison KH, Peacock S, Lehman CD.

Radiology. 2012 May;263(2):374-82. doi: 10.1148/radiol.12111368.

35.

Background parenchymal enhancement on breast MRI: impact on diagnostic performance.

DeMartini WB, Liu F, Peacock S, Eby PR, Gutierrez RL, Lehman CD.

AJR Am J Roentgenol. 2012 Apr;198(4):W373-80. doi: 10.2214/AJR.10.6272.

PMID:
22451576
36.

Improved B1 homogeneity of 3 Tesla breast MRI using dual-source parallel radiofrequency excitation.

Rahbar H, Partridge SC, Demartini WB, Gutierrez RL, Parsian S, Lehman CD.

J Magn Reson Imaging. 2012 May;35(5):1222-6. doi: 10.1002/jmri.23571. Epub 2012 Jan 26.

37.

Characterization of ductal carcinoma in situ on diffusion weighted breast MRI.

Rahbar H, Partridge SC, Eby PR, Demartini WB, Gutierrez RL, Peacock S, Lehman CD.

Eur Radiol. 2011 Sep;21(9):2011-9. doi: 10.1007/s00330-011-2140-4. Epub 2011 May 12.

PMID:
21562806
38.

The utility of breast MRI as a problem-solving tool.

Yau EJ, Gutierrez RL, DeMartini WB, Eby PR, Peacock S, Lehman CD.

Breast J. 2011 May-Jun;17(3):273-80. doi: 10.1111/j.1524-4741.2011.01075.x. Epub 2011 Apr 8.

PMID:
21477168
39.

Probability of malignancy for lesions detected on breast MRI: a predictive model incorporating BI-RADS imaging features and patient characteristics.

Demartini WB, Kurland BF, Gutierrez RL, Blackmore CC, Peacock S, Lehman CD.

Eur Radiol. 2011 Aug;21(8):1609-17. doi: 10.1007/s00330-011-2094-6. Epub 2011 Feb 27.

PMID:
21359910
40.

Improved diagnostic accuracy of breast MRI through combined apparent diffusion coefficients and dynamic contrast-enhanced kinetics.

Partridge SC, Rahbar H, Murthy R, Chai X, Kurland BF, DeMartini WB, Lehman CD.

Magn Reson Med. 2011 Jun;65(6):1759-67. doi: 10.1002/mrm.22762. Epub 2011 Jan 19.

41.

High cancer yield and positive predictive value: outcomes at a center routinely using preoperative breast MRI for staging.

Gutierrez RL, DeMartini WB, Silbergeld JJ, Eby PR, Peacock S, Javid SH, Lehman CD.

AJR Am J Roentgenol. 2011 Jan;196(1):W93-9. doi: 10.2214/AJR.10.4804.

PMID:
21178040
42.

Targeted ultrasound in women younger than 30 years with focal breast signs or symptoms: outcomes analyses and management implications.

Loving VA, DeMartini WB, Eby PR, Gutierrez RL, Peacock S, Lehman CD.

AJR Am J Roentgenol. 2010 Dec;195(6):1472-7. doi: 10.2214/AJR.10.4396.

PMID:
21098212
43.

Breast MRI in community practice: equipment and imaging techniques at facilities in the Breast Cancer Surveillance Consortium.

DeMartini WB, Ichikawa L, Yankaskas BC, Buist D, Kerlikowske K, Geller B, Onega T, Rosenberg RD, Lehman CD.

J Am Coll Radiol. 2010 Nov;7(11):878-84. doi: 10.1016/j.jacr.2010.06.019.

44.

Atypical ductal hyperplasia on vacuum-assisted breast biopsy: suspicion for ductal carcinoma in situ can stratify patients at high risk for upgrade.

Allison KH, Eby PR, Kohr J, DeMartini WB, Lehman CD.

Hum Pathol. 2011 Jan;42(1):41-50. doi: 10.1016/j.humpath.2010.06.011. Epub 2010 Oct 20.

PMID:
20970167
45.

Frequency, upgrade rates, and characteristics of high-risk lesions initially identified with breast MRI.

Strigel RM, Eby PR, Demartini WB, Gutierrez RL, Allison KH, Peacock S, Lehman CD.

AJR Am J Roentgenol. 2010 Sep;195(3):792-8. doi: 10.2214/AJR.09.4081.

PMID:
20729462
46.

Probably benign lesions detected on breast MR imaging.

Eby PR, DeMartini WB, Gutierrez RL, Lehman CD.

Magn Reson Imaging Clin N Am. 2010 May;18(2):309-21, x. doi: 10.1016/j.mric.2010.02.006. Review.

PMID:
20494314
47.

Apparent diffusion coefficient values for discriminating benign and malignant breast MRI lesions: effects of lesion type and size.

Partridge SC, Mullins CD, Kurland BF, Allain MD, DeMartini WB, Eby PR, Lehman CD.

AJR Am J Roentgenol. 2010 Jun;194(6):1664-73. doi: 10.2214/AJR.09.3534.

PMID:
20489111
48.

Differential diagnosis of mammographically and clinically occult breast lesions on diffusion-weighted MRI.

Partridge SC, Demartini WB, Kurland BF, Eby PR, White SW, Lehman CD.

J Magn Reson Imaging. 2010 Mar;31(3):562-70. doi: 10.1002/jmri.22078.

PMID:
20187198
49.

Risk of upgrade of atypical ductal hyperplasia after stereotactic breast biopsy: effects of number of foci and complete removal of calcifications.

Kohr JR, Eby PR, Allison KH, DeMartini WB, Gutierrez RL, Peacock S, Lehman CD.

Radiology. 2010 Jun;255(3):723-30. doi: 10.1148/radiol.09091406. Epub 2010 Feb 19.

PMID:
20173103
50.

Diffusion tensor MRI: preliminary anisotropy measures and mapping of breast tumors.

Partridge SC, Ziadloo A, Murthy R, White SW, Peacock S, Eby PR, DeMartini WB, Lehman CD.

J Magn Reson Imaging. 2010 Feb;31(2):339-47. doi: 10.1002/jmri.22045.

PMID:
20099346

Supplemental Content

Loading ...
Support Center